TDC
62
-5
SPG
40
2
AMZN
38
2
AVGO
40
2
XOM
54
-2
LOW
45
2
ZBH
53
2
T
50
2
EQT
84
5
COF
49
2
GOOG
51
9
FTI
86
4
IVZ
45
3
SYF
37
5
NI
73
5
EA
38
2
FIS
38
4
MCD
54
2
AXP
59
3
AFL
44
2
TDC
62
-5
SPG
40
2
AMZN
38
2
AVGO
40
2
XOM
54
-2
LOW
45
2
ZBH
53
2
T
50
2
EQT
84
5
COF
49
2
GOOG
51
9
FTI
86
4
IVZ
45
3
SYF
37
5
NI
73
5
EA
38
2
FIS
38
4
MCD
54
2
AXP
59
3
AFL
44
2
Financhill
Back

Universe Pharmaceuticals, Inc. 10K Form

Sell
10

UPC
Universe Pharmaceuticals, Inc.

Last Price:
$2.85
Seasonality Move:
1.61%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive UPC News And Ratings

See the #1 stock for the next 7 days that we like better than UPC

UPC Financial Statistics

Sales & Book Value

Annual Sales: $17.9M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $110.01
Price / Book: 0.04

Profitability

EPS (TTM): -76.35000
Net Income (TTM): $-18.5M
Gross Margin: $5.9M
Return on Equity: -49.07%
Return on Assets: -32.15%

Universe Pharmaceuticals, Inc. Earnings Forecast

Key Universe Pharmaceuticals, Inc. Financial Ratios

  • The Gross Profit Margin over the past 8 years for UPC is 32.93%.
  • The Selling, General & Administrative Expenses for UPC have been equal to 47.85% of Gross Profit Margin.
  • The Research & Development expenses have been 2.78% of Revenue.
  • The Net Earning history of UPC is -20.56% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 4 years.

Universe Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: UPC
Website: universe-pharmacy.com

Debt

Debt-to-Equity Ratio: 0.24
Current Ratio: 1.63
Quick Ratio: 1.25

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

UPC Technical Analysis vs Fundamental Analysis

Sell
10
Universe Pharmaceuticals, Inc. (UPC) is a Sell

Is Universe Pharmaceuticals, Inc. a Buy or a Sell?